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The Centers for Disease Control and Prevention
(CDC) estimates that approximately 40,000 new HIV
infections occur each year in the United States.
Furthermore, estimated national HIV incidence has
remained virtually unchanged for more than a
decade and there are signs of increasing risk
behavior, and even incidence, in some
communities.1
In an effort to augment HIV prevention efforts, health
policy experts, researchers, medical providers,
government officials and community members have
increasingly focused on the importance of integrating
prevention into the clinical care setting, finding new
opportunities to reach those at risk for and living with
HIV when and where they interact with the health
care delivery system.2 Studies show, however, that
HIV prevention, including risk assessment and
prevention education and counseling, is not a routine
part of clinical care in the United States. Indeed,
there are many barriers to doing so. Research has
increasingly examined some of these barriers with a
specific focus on the role of the health care provider.
Much less attention has been given to the structural
and systems-level factors that enable, or inhibit,
integration. These include the many legal, financial,
and organizational factors that guide or constrain
policy and clinical decision-making at the federal,
state, and local levels. Attention to these factors may
provide additional opportunities for enhancing HIV
prevention integration activities.
This policy brief examines the structural-level
opportunities and challenges associated with the
delivery of HIV prevention services in or closely
linked to the clinical care setting. It focuses on two
of the major public programs for HIV care in the U.S:
Medicaid, the nation’s major public health program
for low-income Americans, and the largest source of
public financing for HIV/AIDS care in the U.S.; and
the Ryan White CARE Act, the nation’s only HIV-
specific care and support services grant program
which operates as the payer of last resort at the
state and local level. Together, these programs
provide care and support services to a significant
proportion of those at risk for and living with HIV and
therefore provide an important focus for assessing
current prevention integration practice, identifying
strategies to enhance integration, and targeting such
efforts.
The brief reviews the legislative and statutory
authorities governing the Medicaid and Ryan White
programs to assess the extent to which current law
allows for the provision and financing of HIV
prevention services. It also examines, to the extent
possible, current practice by these two programs.
The main findings are as follows:
•  Current law already allows for the delivery and
financing of most HIV prevention services through
the Medicaid and Ryan White CARE Act
programs.
•  Available data suggest, however, that in practice,
neither program is currently delivering a significant
amount of HIV prevention services to their
beneficiaries/clients.
•  The provision of HIV prevention services by the
Medicaid and Ryan White programs would, in most
cases, require affirmative policy decisions at the
state and local level and would likely require
additional resources and/or the shifting of
resources to support prevention delivery. Current
fiscal pressures facing both Medicaid and Ryan
White will make it unlikely that either can initiate
and/or enhance the provision of prevention
services at this time.
•  Even if fiscal constraints were not a limitation, both
the Medicaid and Ryan White programs face other
organizational and systems-level barriers that
complicate the integration of prevention into the
clinical care setting and each would benefit from
guidance and technical assistance in many areas.
Such guidance would also be important for those
efforts that may be currently underway.
This brief provides several options for research,
technical assistance and policy that could serve to
enhance opportunities for integration of HIV
prevention and care including: development and
dissemination of integration models; review of
financing and coverage policies by federal agencies;
development of federal guidance on integration; and
a variety of specific technical assistance and training
activities that could be pursued.
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Executive Summary

Introduction
Health policy experts, researchers, medical
providers, government officials and community
members have increasingly recognized the
importance of augmenting existing prevention efforts
by expanding their reach into the clinical care
setting.1,2,3,4,5,6,7,8,9,10,11 As stated in the Institute of
Medicine’s (I0M), No Time To Lose: Getting More
From HIV Prevention, “… the clinical care setting
provides opportunities for integrating prevention into
the standard of care for those who are infected or at
high risk.”12 The Centers for Disease Control and
Prevention (CDC) recently released
recommendations for health care providers on the
need to integrate prevention into the clinical care
setting.6 And, a new report from the Global HIV
Prevention Working Group focuses on the urgent
need to integrate prevention and treatment, as
treatment efforts are scaled up globally.13 Studies
show, however, that HIV prevention, including risk
assessment and prevention education and
counseling, is not a routine part of clinical care in the
United States.1,14,15,16,17,18,19,20,21,22,23,24 This is in
part due to structural issues and barriers but these
have not been fully examined—most of the literature
on integrating HIV prevention into primary care has
focused on the role of the health care provider rather
than on the structural factors that enable, or inhibit,
integration.
This policy brief examines the opportunities and
challenges associated with the delivery of HIV
prevention services in or closely linked to the clinical
care setting in the U.S., with a focus on structural
and systems-level barriers and opportunities (e.g.,
financing, delivery systems, and staffing). It looks
specifically at two of the major public programs for
people with HIV/AIDS—Medicaid and the Ryan
White CARE Act—but identifies issues and lessons
more broadly applicable to other programs.
Medicaid, the nation’s major public health program
for low-income Americans, is the largest source of
public financing for HIV care—it is estimated to cover
the care of approximately half of all people with
AIDS, and a substantial portion of those newly
diagnosed with HIV.25,26,27,28 The Ryan White CARE
Act (CARE Act), the nation’s only HIV-specific care
and support services grant program which operates
as payer of last resort at the state and local level, is
estimated to serve over 500,000 uninsured and
underinsured people with HIV/AIDS each year.29 It
is the third largest source of public funding for HIV
care in the U.S.25 Together, Medicaid and the CARE
Act provide care and support services to a
significant proportion of those at risk for and living
with HIV and therefore provide an important focus for
assessing current prevention integration practice,
identifying strategies to enhance integration, and
targeting such efforts. The brief reviews the
legislative and statutory authorities governing the
Medicaid and Ryan White programs to assess the
extent to which current law allows for the provision
and financing of HIV prevention services. It also
examines, to the extent possible, current practice by
these two programs.
Background
Earlier literature and guidance on HIV prevention in
the primary care setting have focused largely on the
role of the health care provider rather than the
structural components that enhance or inhibit the
provision of prevention in the primary care
setting.7,8,9,14 A shift to a more structural approach
began with the IOM’s report, No Time to Lose, which
specifically addresses the importance of system-
level changes needed to integrate HIV prevention
into the clinical care setting. As recommended by
the IOM:
Prevention services for HIV-infected persons should be
a standard of care in all clinical settings (e.g., primary
care settings, sexually transmitted disease clinics, drug
treatment facilities, and mental health settings). Health
care providers should have adequate training, time,
and resources to conduct effective HIV prevention
counseling. Enabling this activity may require
adjustments in health care provider time allocations
and/or specific financial incentives from public and
private sources of health coverage.30
The IOM recommends the development of policy
initiatives and incentives to encourage delivery of
prevention services within public and private
programs, including Medicaid and the Ryan White
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CARE Act. In the context of Medicaid, the IOM
suggests that CDC and the Centers for Medicare and
Medicaid Services (CMS) find ways to encourage
states to adopt important but optional Medicaid
benefits that are prevention-related, such as targeted
case management. Other mechanisms include
enhanced reimbursement rates within the Medicaid
fee-for-service system and the need for states to
incorporate quality assurance measures for HIV
prevention and adequate capitation rates to account
for prevention service delivery within the Medicaid
managed care environment. In the context of the
CARE Act, the IOM suggests that the Health
Resources and Services Administration (HRSA)
foster coordination and provision of prevention
services by CARE Act grantees, such as encouraging
all clinical providers supported with CARE Act funds
to make HIV risk assessment a standard part of care
and permitting referrals to CDC-funded prevention
case management services by CARE Act-funded
case managers.
CDC has undertaken several recent initiatives
consistent with IOM recommendations, reflected in
the Advancing HIV Prevention protocol4 and recently
released recommendations for the integration of
prevention into the clinical care setting:6
Through ongoing attention to prevention, risky
sexual and needle-sharing behaviors among
persons with HIV infection can be reduced and
transmission of HIV infection prevented. Medical
care providers can substantially affect HIV
transmission by screening their HIV-infected
patients for risk behaviors; communicating
prevention messages; discussing sexual and drug-
use behavior; positively reinforcing changes to
safer behavior; referring patients for services such
as substance abuse treatment; facilitating partner
notification, counseling, and testing; and identifying
and treating other sexually transmitted diseases
(STDs).31
The recommendations are intended for all health care
workers who provide medical care to HIV-infected
persons (e.g., physicians, nurse practitioners, nurses,
physician assistants). They may also be used by
those who deliver prevention messages (e.g.,
prevention case managers, social workers, health
educators). While these guidelines focus primarily on
the role of the provider, they do note the importance
of the financing and service delivery environment.
The Importance of the Clinical Care Setting
for Prevention
“HIV prevention” encompasses a wide range of
services important for identifying at-risk and HIV-
infected persons to reduce the risk of transmission
(see Table 1). Many of these prevention services are
compatible with the clinical care setting, and may be
integrated or closely linked with it. In addition, the
medical care setting offers an opportunity to reach a
large cohort of at-risk and HIV-infected persons.
Among those who are already HIV positive, the CDC
estimates that approximately 445,000 (out of an
estimated 850,000 to 950,000 people living with
HIV/AIDS) are receiving ongoing medical care.32
Those at risk for HIV may already be receiving (non-
HIV) medical services in the care setting (e.g., STD
treatment, family planning services, emergency
room care, and others).1
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TABLE 1: HIV Prevention Services
Diagnostic/Assessment
HIV risk assessment
HIV testing and diagnosis
Pre- and perinatal HIV screening
STD screening
STD diagnosis and treatment
Population-based screening in emergency
rooms and ambulatory care settings
Interventions to Reduce the Risk of 
HIV Transmission
HIV education—individual or community
Risk reduction counseling
Partner notification programs
Partner counseling and referral
Pre- and perinatal HIV counseling and
education
Pre- and post-test counseling
Antiretroviral therapy for preventing perinatal
transmission
Intensive counseling (individual, couples, group)
Peer support group or outreach services
Condoms
Needle and Syringe Exchange
Occupational post-exposure prophylaxis for HIV
Prevention case management
Substance abuse treatment
Mental health services
Most HIV testing in the U.S. is done in the medical care
setting33,34 including for those who are at risk and
newly diagnosed with HIV. Analysis of data from the
CDC’s HIV/AIDS Reporting System (HARS) in 25
states found that about half of those diagnosed with
HIV between 1994 and 1999 were tested in an
inpatient (27%) or private medical doctor setting (22%).
Eleven percent were tested at an HIV counseling or
testing site.28 Analysis of data from the CDC’s HIV
Testing Survey (HITS) of those at-risk found that most
were tested in public health clinics, including
community health centers, followed by private doctor’s
offices.35
These data underscore the importance of the clinical
setting as an opportunity to intervene to reduce the
risks associated with HIV transmission. They also
provide critical information about where such
interventions could be targeted.
Precedent for incorporating preventive services into the
routine of clinical medicine can be found in the
experience of numerous other chronic and preventable
illnesses, including: alcohol misuse, obesity, smoking
cessation, asthma, cardiovascular disease, depression,
diabetes, lower back pain, and others.36,37 In addition,
the necessity and challenges of integrating or linking
primary care and prevention services have been well
documented, and provide insight for consideration in
the field of HIV/AIDS.38,39,40,41,42,43 These include:
•  The lack of coverage and reimbursement for
prevention services;
•  The need for data on the costs of interventions,
including cost-benefit and cost-effectiveness data;
•  The need for standardized prevention protocols;
•  Organizational barriers, such as inadequate staffing,
competing provider demands, provider reluctance or
limitations, and an acute-care orientation among
clinical providers;
•  The need to develop new relationships with
community-based prevention providers; and
•  The lack of knowledge or awareness of interventions
(among consumers, providers, and purchasers).
Statutory & Regulatory Considerations: What
HIV Prevention Services Can Be Covered?
Before examining the current role of Medicaid and
Ryan White in providing prevention services to people
at risk for and living with HIV, it is important to
determine the extent to which HIV prevention services
can be covered or offered by these programs, as
governed by their respective statutory and regulatory
authorities.
Medicaid
The federal Medicaid program allows states
significant flexibility to design their own benefits
packages subject to certain minimum
requirements.44,45,46 These requirements include
certain mandatory services that states must
provide in order to participate in the Medicaid
program and receive federal matching funds and
optional services that states can choose to
provide (and receive federal matching funds for
them), but are not required to do. Therefore, to
the extent that a specific HIV prevention-related
service is optional, its coverage would be
dependent on individual state policy decisions.
A legal review of the Medicaid statute was
conducted by The George Washington University,
Center for Health Services Research and Policy
to assess coverage of a range of key HIV
prevention services. Table 2 summarizes
Medicaid statutory coverage for HIV prevention
services as well as limitations by service type. It
is evident that a broad continuum of prevention
services—from risk assessment and HIV
counseling and testing to behavioral health
services—can be reimbursed under Medicaid if
these services are part of the state’s Medicaid
plan or incorporated into a managed care
contract.47 All of the services identified in Table 2
are optional Medicaid services [except in the
context of the Early and Periodic Screening,
Diagnosis and Treatment (EPSDT) Program for
children, or for a family planning visit]. Because
these services are optional, states would need to
make a policy decision to offer them. In addition,
states are limited by several general restrictions
as follows:
•  prohibition against using federal funds for
needle exchange programs;48
•  prohibition against providing services to non-
Medicaid beneficiaries49 (e.g., partner
counseling and notification services and partner
referrals); and
•  prohibition against using non-licensed
practitioners50 (e.g., peer support groups).
Some states have already recognized that
Medicaid reimbursement is currently available to
pay for many key HIV prevention services and are
using various methods of reimbursement
(including: direct fee-for-service reimbursement
and the bundling of behavioral
intervention/prevention services to create new
service categories) for HIV prevention. However,
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HIV Prevention Services Medicaid Coverage1 CARE Act Coverage2
Diagnostic/Assessment
HIV risk assessment Yes Yes
HIV testing and diagnosis Yes Yes
Pre- and perinatal HIV screening Yes Yes
STD screening Yes Yes
STD diagnosis and treatment Yes Yes
Population-based screening in emergency Yes Yes3
rooms and ambulatory care settings
Interventions to Reduce the Risk of 
HIV Transmission
HIV education—individual or community Yes4 Yes5
Risk reduction counseling Yes Yes
Partner notification programs No Yes
Partner counseling and referral Yes4 Yes6
Pre- and perinatal HIV counseling and education Yes Yes
Pre- and post-test counseling Yes Yes
Antiretroviral therapy for preventing Yes Yes
perinatal transmission
Intensive counseling (individual, couples, group) Yes4 Yes7
Peer support group or outreach services No Yes7
Condoms Yes Yes
Needle and Syringe Exchange No No
Occupational post-exposure prophylaxis for HIV Yes8 No8
Prevention case management Yes9 Yes
Substance abuse treatment Yes Yes
Mental health services Yes Yes
NOTES
1 Medicaid statute allows service to be covered by states, either under fee-for-service or Medicaid managed care, and for state to receive
federal matching funds.
2 Coverage may differ by Ryan White CARE Act Title and is generally limited to HIV-infected persons, affected family members, and
persons at-risk for HIV infection.
3 CARE Act Reauthorization of 2000 permits such screenings in CARE Act designated key points of entry.
4 For Medicaid eligibles only.
5 Services may be provided only to eligible persons and family. Outreach services limited to at-risk population for purposes of bringing into
care. Broad public health campaigns and community education not allowable expenses.
6 Services provided only to eligible persons and family members. Title II Partner Notification Grants authorized for administration of
partner counseling and referral services (PCRS) program, currently unfunded by Congress.
7 Services may be provided to individuals without HIV if at high risk for HIV infection.
8 Medicaid: FDA-approved use for occupational post-exposure prophylaxis only; assessment and diagnostic tests may be reimbursable or
covered; Ryan White: funds may only be used to provide therapeutic treatment to HIV-infected persons.
9 See discussion in text.
TABLE 2: Medicaid and The Ryan White CARE Act: Summary of Statutory & Regulatory
Coverage of HIV Prevention Services
INTEGRATING HIV PREVENTION SERVICES 5
no state covers the complete package of prevention
services.
One of the most critical HIV prevention services is
prevention case management (PCM), defined by the
CDC as:
[a] client-centered HIV prevention activity with the
fundamental goal of promoting the adoption of
HIV risk-reduction behaviors by clients with
multiple, complex problems and risk-reduction
needs. PCM is a hybrid of HIV risk-reduction
counseling and traditional case management that
provides intensive, on-going, and individualized
prevention counseling, support, and service
brokerage.51
PCM serves as the primary vehicle for the
management of client prevention needs across a
broad spectrum of service providers (counseling and
mental health, substance abuse, medical care, and
others) and at the same time provides direct patient
education and counseling services. While the term
“PCM” is not used in the Medicaid statute, the
statute does define “preventive services” and “case
management” as follows:
•  “Preventive services” are designed to “(1)
prevent disease, disability, and other health
conditions or their progression (2) prolong life;
and (3) promote physical and mental health and
efficiency.”52
•  “Case management” is designed to assist
Medicaid beneficiaries in “gaining access to
needed medical, social, educational, and other
services.”53
•  In addition, the Medicaid statute allows states to
limit or target the provision of case management
specifically to people with HIV/AIDS and to
certain other groups.54 This is called “targeted
case management,” which is defined in the
same way as case management above.
Case management, including targeted case
management, is an optional Medicaid benefit which
states must choose to provide. States have the
flexibility to design such a benefit in a way that
combines both prevention and case management
services, setting a payment rate for the benefit and
giving it an appropriate name (e.g., HIV Prevention
Case Management). Several options for payment
exist:
•  Payment on a fee-for-service basis, combining
procedure codes for preventive health services
with codes for case management functions;
•  Payment on an all-inclusive encounter-based rate
where the provider is a clinical provider (such as
an FQHC, RHC, or other clinical rate);
•  Payment as part of an overall monthly member
enrollment rate in the case of individuals receiving
services through comprehensive risk-based
managed care plans; or
•  Payment as part of the case management fee paid
to primary care case managers in the case of
persons receiving health care through limited
managed care arrangements known as primary
care case management systems.
Ryan White CARE Act
A legal review was also conducted of the Ryan White
CARE Act. Table 2 (see page 5) summarizes Ryan
White CARE Act coverage for HIV prevention
services as well as limitations. The review found
that, as with Medicaid, the CARE Act also provides
states and localities with broad flexibility to provide a
wide range of preventive services to individuals with
and at risk for HIV infection and their family
members. The definitions of “ambulatory services”
and “early intervention services” in the CARE Act are
broad enough to encompass most prevention
services listed. The CARE Act also has some
flexibility not available under Medicaid. Unlike
Medicaid, CARE Act funds are not bound by
provider licensure requirements. In addition, CARE
Act funds can support services for at-risk persons
and family members (depending on Title-specific
eligibility categories). Recent legislative changes to
the CARE Act expanded further the use of funds for
prevention under different CARE Act Titles.
Actual services provided under the CARE Act vary
by jurisdiction, based on planning and allocation
decisions made by local Planning Councils (Title I),
State Consortia (Title II), and directly funded
grantees (Titles III and IV), although they are subject
to the general parameters of the law discussed
above and numerous Title-specific statutory
requirements (see discussion below about current
practice). The level of available funding may also
limit a jurisdiction’s ability to provide a full range of
prevention services. In addition, the use of funds to
support HIV prevention services through the CARE
Act must comply with “payer of last resort ”
provisions as defined by statute. In the case of
CARE Act funded prevention case management
services, for example, programs are required to use
available CDC (or other federal, county, or local)
funding prior to the use of CARE Act funds for
prevention services. Although CARE Act funds
cannot supplant the funds from other payer sources,
there are numerous examples of the collaborative
financing of PCM services using CARE Act and
CDC funds. For example, New Mexico recently
enacted a state-wide PCM program administered
through state-designated health management
alliances (HMA) that cover four geographic areas
and one Native American community. The PCM is
accomplished through a collaboration of the HMA
and the county health department’s early
intervention nursing services program. The funding
is a mix of state general revenues, HIV prevention
funds from the state health department, and CARE
Act Title II and III grants. The program was built on
the existing case management program supported
by Title II CARE Act funds.
Current Practice
Having established what Medicaid and the CARE
Act can provide in the way of prevention services, it
is important to understand—to the extent this
information is available—the degree to which these
program are already providing such services in
practice.
Medicaid
Very little is known regarding the actual coverage
and financing of prevention-related services for
Medicaid beneficiaries at-risk for or living with HIV
disease. Since some HIV prevention services can
be incorporated into a traditional office visit or other
services covered by Medicaid (e.g., mental health
counseling), it is difficult to determine the degree to
which providers are offering HIV prevention
counseling or related services of some kind.
However, states as managers of their Medicaid
programs often communicate their policy priorities
for services to be provided to their beneficiaries
through their General Service Agreements (GSAs),
their contracts with managed care organizations
(MCOs), and primary care case management
(PCCMs) contracts, their contracts with primary care
providers.55 It is important to note that inclusion
within a contract does not guarantee delivery of
these services. Similarly, their omission does not
necessarily mean that managed care entities are not
providing these services as part of their overall
package of benefits provided to members. However,
inclusion in a contract can mean that HIV prevention
services are included in determining the capitation or
reimbursement rates paid MCOs and their providers.
To examine state Medicaid coverage for HIV
prevention services through managed care contracts,
George Washington University, Center for Health
Services Research and Policy researchers performed
a contract analysis of state GSAs and PCCMs for the
year 2000. Forty-eight states had GSAs for managed
care and/or PCCMs. Key findings include:
•  The majority of states (32 of 48) covered HIV
testing and counseling and STD testing and
treatment services;
•  19 of 48 states included prenatal and perinatal
counseling and testing requirements;
•  7 of 48 states specified coverage for behavioral
interventions such as substance abuse and mental
health services, including intensive counseling and
HIV prevention counseling;
•  4 of 48 states included HIV risk assessment in
their Medicaid managed care/PCCM contracts.
Two targeted family planning and 2 targeted at-risk
and adult enrollees;
•  3 states allowed for beneficiaries to use
anonymous or confidential HIV testing sites and to
reimburse sites for such services;
•  2 of 48 states included provisions for case
management coupled with prevention education.
No state covered direct prevention case
management; and
•  No state provided additional or specific financial
reimbursement for covered HIV prevention
services.
These findings indicate that, beyond HIV testing and
counseling, few states explicitly covered HIV
prevention services under GSA and PCCM contracts
and, to the extent that other services were covered,
states tended to limit coverage to specific target
populations.
Ryan White CARE Act
Historically, CARE Act funding for HIV prevention
services was limited largely to Title III (direct federal
grants to community-based providers for clinical
care) and Title IV (network development to support
research and care for women and children)
programs, as well as to “early intervention services”
only—specifically, HIV counseling and testing,
education, and referral services. The reauthorization
of the CARE Act in 2000 expanded coverage for
early intervention services under Titles I and II, the
federal grants to eligible metropolitan areas and
states, respectively. All Titles have had flexibility to
support targeted outreach activities, as clarified in
the 2000 reauthorization.
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In order to assess coverage of HIV prevention
services through Ryan White CARE Act programs, a
survey of all CARE Act grantees and their
subcontractors was conducted between
1999–2000.56 Findings from the survey highlight the
significant role of CARE Act providers in providing
HIV prevention services.
•  Almost half (47%) reported delivering prevention
services. These organizations receive funding
through a patchwork of entitlement and
discretionary grant programs including Medicaid
and Titles I, II, III, and IV of the CARE Act;
•  One-third of the CARE Act grantees and
subcontractors surveyed reported receiving CDC
funds to support HIV prevention services;
•  CARE Act-funded community-based prevention
providers were more likely to provide HIV
counseling and testing than CARE Act-funded
medical and other clinical providers (67% vs. 55%,
respectively). These providers were also more
likely to provide for case finding activities and
outreach;
•  Community-based organizations (49%) were more
likely to provide prevention services than public
health departments (17%), community health care
centers (10%), hospital outpatient programs (9%),
and mental health and substance abuse agencies
(3%); and
•  Minority agencies57 were more likely to provide
prevention services than non-minority agencies
(42% vs. 35%).
These findings highlight several important issues
including:
•  The majority of HIV prevention services delivered
by CARE Act funded programs were provided by
prevention and social services providers and not
clinical care providers or within health care
settings;
•  Relatively few CARE Act providers received CDC
funding for prevention service delivery;
•  CDC-funded prevention programs were generally
located in community-based prevention agencies
and health departments as opposed to clinical
settings and/or CARE Act-funded sites; and
•  While minority providers have developed capacity
to provide prevention services, their capacity
remains limited and programs may not be linked or
integrated into other social service and clinical
services and providers.
Organizational Issues In Incorporating
Prevention Into the Clinical Care Setting
Regardless of coverage or care source, to the extent
that clinical providers and institutions may be
interested in providing HIV prevention services for
their clients, several key organizational factors may
impact delivery and management, including:
•  Benefits coverage and reimbursement levels,
including the methods of determining service
costs;
•  The challenge of coordinating funding streams;
•  Operational issues such as establishing HIV
prevention service standards, protocols, and
operating procedures for purpose of delivering,
monitoring, and contracting for prevention
services; and
•  The challenge of developing community-based
prevention-care networks
Benefits Coverage and Reimbursement for HIV
Prevention Services
As indicated by the review of statutory and
regulatory provisions, many HIV-related prevention
services can be reimbursed under Medicaid or paid
for under the CARE Act. However, without explicit
policies regarding reimbursement of HIV prevention
services specifically, these services may be treated
as uncovered benefits or expected to be delivered,
as commonly is the case for HIV counseling and
education, with limited or no monetary compensation
for medical care professionals.1,58,59
As described above, few state Medicaid managed
care contracts cover services beyond the traditional
HIV counseling and testing provisions and, to the
extent that such services are covered, states tend to
limit the coverage to specific target populations (e.g.,
family planning service clients). No state has
developed adjusted (reimbursement and/or
capitation) rates in Medicaid to compensate for a
wide array of HIV prevention services delivered in
the context of providing HIV clinical care.
One challenge to developing such rates is
determining costs. To date, cost information on HIV
prevention services is limited and generally
restricted to studies of the cost-benefit or cost-
effectiveness of certain types and locations of HIV
counseling and testing services and other
interventions.60,61,62 Beyond these studies, the costs
for many HIV prevention services remain largely
unknown and claims files to determine direct and
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indirect costs are usually unavailable. To determine
costs, prevention services program administrators,
or clinics that provide prevention services, would
need client-level tracking systems to determine
prevention service use, costs and revenues. This
would include the need to define the type of service
(i.e., what is “prevention counseling”), provider roles,
and service outcomes in order to establish methods
of determining reasonable reimbursement levels.
The definition and scope of a service (e.g., HIV
education services defined as the distribution of
literature/pamphlets or a face-to-face patient-
provider interaction), professional fees and other
direct and indirect costs, cost information to
determine overall expenditures and revenues, and
established billing procedures will all impact on
whether the provider has the information and
systems necessary to adequately determine costs
and obtain reimbursement.
Some of the groundwork for this type of effort has
been laid within the CARE Act. Over the past
several years, CARE Act grantees have established
various means of determining and reimbursing for
other CARE Act funded services. Many grantees
have moved to calculating “unit costs” for the
reimbursement of specific CARE Act services. “Unit
cost” is defined as the cost to produce or deliver one
unit of a product or service. While unit costing is
increasingly used by grantees with HIV-related
medical services, it has not yet been applied to
prevention services, and there are several key
elements that would be needed to calculate
prevention service costs.63 These include: uniform
service taxonomy (e.g., type of service to be
delivered and the definition of the “unit”); variable
reimbursement rates among providers for the same
units to adjust for service intensity and quality;
standards and protocols for delivery of prevention
services (e.g., role of provider, clinic resources); a
client-level tracking system to monitor costs and
revenues for all services; and an organizational
acceptance of the philosophy about the role and
purpose of unit costing. Since receiving legislative
authority to provide prevention services under the
2000 CARE Act Reauthorization, Titles I and II
grantees are currently in the process of determining
scope of coverage and methods of reimbursement.
At this time, it is not clear if unit costing will evolve
into the predominant means of supporting CARE Act
funded prevention services.
Coordination of Funding Streams
There are no national standards or expectations for
the development, implementation, or financing of a
coordinated and/or integrated prevention and care
service environment. Discretionary federal grant
programs [such as prevention funding through CDC,
Ryan White CARE Act funding through HRSA, and
substance abuse and mental health prevention and
care funding through the Substance Abuse and Mental
Health Services Administration (SAMHSA)] and state
Medicaid programs do not require the coordination of
the management, disbursement, and/or planning of
local prevention funds. This has resulted in multiple
authorities having responsibility for the planning and
disbursement of funds, and a patchwork of potentially
uncoordinated and/or duplicative prevention and care
services. Efforts to coordinate the planning or
allocation of funds to support coordination between
prevention and care services and providers remain a
responsibility primarily for local jurisdictions or agencies
with sometimes distinct and conflicting planning
priorities and/or organizational missions and little
guidance for establishing mechanisms to systematically
assess areas of targeted prevention needs (for
populations and types of services), expectations for the
coordination of service networks to address these
areas of need, and standards for financing and
reimbursing prevention services to these communities.
In addition, CDC funds provided to state health
departments for the support of HIV prevention services
are allocated through a separate community prevention
planning process that does not necessarily include
Medicaid, CARE Act, and other federally-funded care
and prevention programs. Further, as described in the
analysis of HIV prevention service coverage among
CARE Act grantees, CDC funding for prevention
services is generally located outside of the HIV clinical
care setting. To date, CDC does not have a
mechanism to systematically track grant funding to
prevention providers, either at the direct grantee or
subgrantee level, to determine the actual investment of
funding or effectiveness of prevention services in or
outside of the HIV clinical care setting.
Operational Issues
Providers are faced with several operational challenges
to integrating prevention into the continuum of services
provided in clinical care setting. These include:
•  expansion of the mission and scope;
•  changing staffing responsibilities and roles for
physician providers and other medical and non-
medical staff; and
•  incorporation of standardized protocols and operating
procedures for the acquisition, delivery and
monitoring of prevention services.
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Expanding the scope and mission of the health care
organization is a difficult process for any organization.
Clinical care settings planning to deliver HIV
counseling, testing, and referral services or other
types of HIV prevention services (e.g., risk reduction
counseling, prevention case management, and
education) will confront numerous procedural,
organizational, legal and policy issues. Determining
the scope and intensity of prevention services
requires a planning mechanism to assess the relation
of these new services to the health care needs of
clients, its compatibility with the original mission of the
institution, the staffing and management resources
necessary to deliver such services, business relations
and referral opportunities with external providers and
organizations, and short- and long-term funding
resources to support services. Previous experience in
providing such services and organizational capacity
(e.g., laboratory services, information reporting and
claims management systems, behavioral health staff,
and others) will affect the likelihood of being able to
provide and monitor certain types of HIV prevention
services. State and federal laws regulating patient
information (e.g., federal confidentiality and privacy
laws, such as HIPAA64) and the types of services and
professional requirements will influence the level of
coverage and delivery of services.
Numerous staffing issues face organizations wishing to
integrate prevention into the clinical care setting. Given
the multifactorial nature of individual behavior, access to
various medical and non-medical clinic staff is
necessary. Medical providers play an important role as
the patient’s primary point of contact with the medical
system. In this role, providers have opportunities to
assess patient risk, provide referrals to prevention or
other clinical services, and establish a supportive, open
environment for discussion and reinforcing risk
reduction and prevention practices. However, the
likelihood that at risk or HIV-infected persons will
receive prevention services as part of the clinical
encounter this will be affected by such factors as:
•  medical provider beliefs and characteristics (i.e.,
perceived value of HIV prevention efforts; personal
beliefs or comfort associated with discussing sex or
drug using behaviors; attitudes toward HIV-infected
persons);
•  lack of administrative supports (i.e., routine risk
assessment tools; financial resources; referral
information; standards or protocols for HIV
prevention services); and
•  patient-provider time constraints.
The new CDC guidelines for prevention in the primary
care setting are an attempt to address some of these
challenges.6
In addition to medical providers, other health
professional and non-professional staff play an important
role in delivering HIV prevention services. Behavioral
health staff (mental health and addiction services
professionals), nurse educators and case managers, risk
reduction counselors, health educators and prevention
case managers, peer outreach workers and counselors,
and others provide an array of complementary
prevention services. Incorporating these staff into the
clinical setting may require changes to existing
management and organizational structures, as
mentioned above, and the need to develop a
“prevention-care team.” Cultural and language needs of
clients may need to be incorporated into this prevention-
care approach and could be accomplished via these
additional staff.
Incorporating HIV prevention services in the clinical
setting will also require the standardization of these
services for purposes of establishing quality measures,
professional responsibilities, practice guidelines,
decision models, and cost-effectiveness analysis.
Prevention interventions, however, are intrinsically less
standardizable than medical procedures. Problems exist
within several key areas:
•  translating HIV prevention and epidemiologic
transmission research findings into practical clinical
guidelines for providers;
•  defining the preventive service (i.e., what is a health
education encounter) in order to establish procedural
guidelines, roles and responsibilities of  medical and
non-medical providers, the unit of service, and direct
and indirect service costs;
•  establishing information systems necessary for
assessing service utilization, costs, program
effectiveness, and quality control and monitoring; and
•  establishing evaluation criteria for purposes of
determining program outcomes, cost-effectiveness,
contract compliance and program accreditation.
To date, several federal and state agencies have begun
investigating these issues for a limited scope of HIV-
related prevention services.65 However, most of the
development of standards for prevention/behavioral
intervention services standards has occurred within the
context of the contracting for behavioral health services,
as this relates to quality monitoring and accreditation for
private and public behavioral managed healthcare
organizations.66
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A recent study of HIV positive patients in HIV
primary care found that those seen in clinics with
specific, written HIV prevention procedures were
significantly more likely to report receiving HIV
prevention counseling compared to patient seen in
clinics without written procedures, underscoring the
need for such standards and guidance.67
Community-based Prevention-Care Networks:
Linking Community-based Prevention Providers
to Clinical Care Settings
Establishing linkages between clinical care settings
and community-based prevention providers is
essential to creating a comprehensive prevention-
care service environment. Once a clinical provider
has identified high-risk behaviors of an at-risk or
HIV-infected patient, the provider referral process
and established network relations are critical to
linking patients from the clinical setting to prevention
services. Key elements in engaging and sustaining
clients in the prevention and care system include the
need to assess the full range of client needs, identify
adequate referral services and programs, establish
meaningful contact and relations with such referral
programs, and provide follow-up to determine
referral success.38 Numerous referrals may be
necessary to address the myriad of behavioral
issues facing the client (e.g., mental health needs,
access to direct interventions such as condoms or
clean syringes/needles, case finding and partner
education and counseling, addictive disorder and
recovery services, couples counseling, and others)
or the complex array of social issues impacting on
the clinical care of the client.68
The types of providers included within a network
need to be dependent on the populations being
served and draw from a range of types of providers
such as prevention case management providers,
family planning clinics, STD clinics, ERs, HIV care
providers and clinics, mental health and addictive
disorder services, HIV risk reduction counseling and
education, peer support services and outreach, and
others. These providers would need to be
responsive to the array of social, cultural, and clinical
needs of the local at risk or HIV-infected community.
Additional issues in developing such a network
include: the oversight of management of the network
(e.g., use of a “collaboration manager”); private
sector involvement; methods of monitoring and
tracking clients for quality and evaluation activities;
data sharing among Medicaid, providers, and public
health agencies; establishing meaningful business
relations and adequate financial resources; and
agency-specific measures for building staff and clinic
skills and designating resources for establishing relations
with other providers.
Complicating these challenges is the fact that prevention
service providers—predominantly social service (or
behavioral services) organizations located within the
community—are frequently fragmented from the clinical
care setting. Interactions between these parties are
often dependent upon personal relations and common
organizational missions or goals, organizational and
business relations, available entitlement and
discretionary funding sources, and a familiarity with and
appreciation for the utilization of services for specific
client needs.39,69,70 In addition, providers needed to
respond to the range of client prevention needs may not
be available or accessible within all communities. Finally,
there are few described and/or well disseminated models
on prevention-care networks from either federal agencies
or local community-based programs.71
Case management has historically assumed the role of
coordinating the medical and support service needs of the
clients. However, the use of prevention case managers to
coordinate prevention services (and provide prevention
education and counseling) remains relatively rare with
limited evaluation data available.51 The role and models of
the prevention case manager (including methods of
coverage and reimbursement) in relation to the clinical
care setting are relatively undeveloped. Recently, several
states have started to explore methods of creating
prevention case management programs through blending
and consolidating of prevention and care case
management services and federal funds. For example,
Kansas Department of Health and the Environment, the
grantee of Title II CARE Act funds, recently expanded
upon existing CARE Act supported case management to
include prevention education and counseling activities,
thus, establishing a prevention case management system
providing both clinical and prevention coordination.
Additional funds for this service are provided through the
CDC state prevention grant.
Any of the above issues collectively, or on their own, may
raise serious barriers to client access to or use of
prevention services. Developing and implementing a
comprehensive and negotiable (i.e., patient friendly)
prevention-care service system requires deliberate acts
of network development, management, and financing.
Models describing pathways among testing, care, and
prevention services need to outline the organizational
and financial features necessary for supporting a
continuum of prevention-care services and the
acquisition of sustainable diverse resources to support
these models.
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The clinical care setting offers a unique opportunity
to reduce HIV transmission among a large number of
at risk and HIV-infected persons and their partners
and family members. In this policy brief, we have
presented a series of structural and systems-level
issues that support, as well as complicate, the
process of integrating prevention into primary care.
A review of the legislative and statutory authorities
governing the Medicaid and Ryan White programs,
their current practice, and relevant literature indicate
the following:
•  Current law already allows for the delivery and
financing of most HIV prevention services through
the Medicaid and Ryan White CARE Act programs.
•  Available data suggest, however, that in practice,
neither program is currently delivering a significant
amount of HIV prevention services to their
beneficiaries/clients.
•  The provision of HIV prevention services by the
Medicaid and Ryan White programs would, in most
cases, require affirmative policy decisions at the
state and local level and would likely require
additional resources and/or the shifting of
resources to support prevention delivery. Current
fiscal pressures facing both Medicaid and Ryan
White will make it unlikely that either can initiate
and/or enhance the provision of prevention
services at this time.
•  Even if fiscal constraints were not a limitation, both
the Medicaid and Ryan White programs face other
organizational and systems-level barriers that
complicate the integration of prevention into the
clinical care setting and each would benefit from
guidance and technical assistance in many areas.
Such guidance would also be important for those
efforts that may be currently underway.
While this brief is focused primarily on Medicaid and
Ryan White, the challenges and opportunities
identified may have broader application to other
federal programs that fund HIV prevention and care
services and suggest additional areas for research,
technical assistance, and policy initiatives that could
be undertaken by federal and state agencies and
their partners to enhance integration of prevention
and care services. Many of these options would
require the federal agencies responsible for funding
care and prevention services (CDC, HRSA, CMS,
SAMHSA, and others) to collaborate in order to
promote the coordination, staff development, and
fiscal sustainability of integrating or linking
prevention and care services. State and local
governments and program administrators would
need to target resources to clinical care settings
used by at risk and HIV-infected persons and
support organizational and staffing arrangements
that foster the provision of both prevention and care
services. As mentioned above, current fiscal
constraints faced by both state Medicaid programs
and discretionary HIV/AIDS programs such as the
CARE Act not only make it difficult to maintain
existing coverage levels, they render it unlikely that
additional resources could be made available to
support the integration of HIV prevention at present.
At the same time, coordination of funding streams
could lead to greater efficiencies.
To the extent that some states and programs are
already integrating prevention into the clinical care
setting or for those that wish to do so, following are
several options for research, technical assistance,
and policy that could serve to enhance opportunities
for integration of HIV prevention and care:
•  Development and dissemination of models of
integration of prevention in primary care and
models of good working relationships between
traditional prevention providers and clinical care
settings.
•  Review of financing and coverage policies by
federal agencies (CMS, HRSA, CDC, SAMHSA) in
Medicaid, Ryan White CARE Act, CDC funded
programs, and SAMHSA block grants to determine
whether policy guidance given grantees promotes
inclusion of prevention services and/or that
explicitly permit these services. This review would
include assessment of potential incentives to
encourage states and grantees to cover integrated
prevention services. One option would be to
create cooperative grant activities that promote the
integration or linkage of prevention and care
services.
•  Provision of technical assistance to assist CDC-
funded grantees in taking advantage of
opportunities to provide prevention in the primary
care setting, including establishing working
relationships with primary care providers/clinics,
assessing both the availability of other funding
streams and of billing procedures.
Conclusion and Policy Implications
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•  Provision of technical assistance and training
opportunities for program administrators to assist
in the development of integrated or linked
networks, including: evaluation, tracking, and
billing systems; organizational and business
arrangements; incorporation and use of practice
standards and protocols for medical and non-
medical staff; and methods of planning,
monitoring, and providing ongoing management
support for the network.
•  Training of health care providers on the
incorporation of HIV prevention practices (e.g., risk
assessment, counseling, and referral activities)
into routine practice activities, including the
development and use of written guidelines and
protocols.
•  Review of policies and guidances to determine if
impediments exist to the development and use of
non-health professionals for the provision of peer
outreach, education, and counseling activities.
•  Exploration of opportunities to increase the use of
prevention case management under Medicaid,
including changing policies and billing procedures
to permit appropriate Medicaid reimbursement.
•  Facilitation of discussions between state Medicaid
and public health agency directors and staff on
developing a prevention-care system for HIV
prevention and its incorporation into existing state
efforts including disease management programs
and billing procedures.
•  Review of state Medicaid managed care contracts
to assure that comprehensive services, including
prevention services, are included. One instrument
available to assess these contracts is a set of
sample purchasing specifications for HIV/AIDS,
developed by GWU under contract from HRSA.72
These purchasing specification guidelines can also
be used more broadly as a checklist of
comprehensive prevention services across
multiple payers and providers.
•  Development of guidance by CMS for state
Medicaid programs regarding inclusion of HIV
prevention services in all forms of managed care
arrangements. Technical assistance could be
provided to both Medicaid and public health staff
at the state level regarding coordination of the
planning and implementation of HIV prevention
services funded by Medicaid programs.
In short, much work needs to be done at all levels of
government and care and prevention service
provision to assure the successful implementation of
the Institute of Medicine’s recommendation that
prevention services for HIV-infected become the
standard of care in all clinical settings, as well as the
CDC’s Advancing HIV Prevention strategy. This brief
has shown that the methods are available and the
relevant programs have much flexibility to
accomplish the integration of HIV prevention in
primary care if these challenges are addressed.
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